Keros Therapeutics (KROS) EBT Growth (3y) (2022 - 2025)
Keros Therapeutics (KROS) EBT Growth (3y) (2022 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
28.95% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-49.71% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
20.92% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
12.01% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Keros Therapeutics |
378.54 Mn |
91.14 Mn |
- |
5.63% |
| Date | Value |
|---|
| Dec 31, 2025 |
5.63% |
| Sep 30, 2025 |
28.19% |
| Jun 30, 2025 |
-6.48% |
| Mar 31, 2025 |
104.51% |
| Dec 31, 2024 |
-109.95% |
| Sep 30, 2024 |
-37.58% |
| Jun 30, 2024 |
-42.56% |
| Mar 31, 2024 |
-39.64% |
| Dec 31, 2023 |
-63.26% |
| Sep 30, 2023 |
-53.20% |
| Jun 30, 2023 |
-56.63% |
| Mar 31, 2023 |
-47.70% |
| Dec 31, 2022 |
-121.06% |
| Sep 30, 2022 |
-87.81% |
| Jun 30, 2022 |
-112.21% |
| Mar 31, 2022 |
-96.60% |
